States' COVID-19 Mitigation Policies and Psychological Health, Drug Overdose, and Suicide among U.S. Adults
各州的 COVID-19 缓解政策以及美国成年人的心理健康、药物过量和自杀
基本信息
- 批准号:10683222
- 负责人:
- 金额:$ 41.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-30 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAdverse effectsAffectAgeBayesian ModelingBlack PopulationsBuffersBusinessesCOVID-19COVID-19 impactCOVID-19 pandemicCOVID-19 preventionCOVID-19 severityCause of DeathCollaborationsConflict (Psychology)CountyDataData CorrelationsData ReportingData SetDeteriorationDisparityEconomicsEducationElderlyEmploymentEthnic OriginFamilyFinancial HardshipFundingGenderGeographyHealthHealth PersonnelHealthcareIndividualLife Cycle StagesLiving ArrangementMeasuresMedicaidMental DepressionMental HealthMethodsNatural experimentNot Hispanic or LatinoOutcomeOverdosePatient Self-ReportPersonal SatisfactionPersonsPharmaceutical PreparationsPlayPoliciesPopulationRaceReportingRiskSARS-CoV-2 infectionSchoolsSleep DisordersSocial isolationSubgroupSuicideSurveysSystemUnemploymentVariantVital StatisticsWorkadverse outcomeage groupagedbasecombatdesignexperiencefuture pandemichealth care availabilityhigh dimensionalityinnovationlarge scale datamembermortalitynovelpandemic diseaseresponseself-reported anxietysexsocialsocial relationshipsstay-at-home ordersubstance usesuicide mortalitysuicide ratetrend
项目摘要
The COVID-19 pandemic and the mitigation policies it prompted may have had profound consequences for the
psychological health of U.S. adults, including their risk of dying from drug overdose and suicide. To mitigate the
spread of COVID-19, some U.S. states enacted policies like stay-at-home orders and business closures. To
mitigate adverse economic and health effects, some states enacted policies like eviction moratoria and extended
unemployment benefits. These policies may have affected adults’ psychological health and related mortality
through social isolation, work-family conflict, interpersonal strain, economic wellbeing, employment disruptions,
and more. The overarching objective of this proposal is to rigorously assess how state-level COVID-19
mitigation policies have affected psychological health and related mortality from drug overdose and suicide
among working age and older adults. The project is significant and will have a sustained impact because it: 1)
identifies how states’ mitigation policies affect psychological health and mortality in both the short and longer-
terms, 2) leverages adults’ self-reports of how COVID-19 and mitigation policies affected their lives and
psychological health with county-level administrative data on drug overdose and suicide mortality, and 3)
empirically develops meaningful composite measures of state mitigation policies to assess their impact on
psychological health and mortality. The project is innovative in that it: 1) uses and extends novel survey data
from working-age adults on how the pandemic and its mitigation policies affected their lives, 2) uses recently-
developed methods for analyzing large contextual datasets containing high-dimensional and correlated data and
3) focuses on the impacts of policies on psychological health and related causes of death, specifically drug-
overdoses and suicides, in the short and longer terms. The project will accomplish its objective through three
Specific Aims. Aim 1 identifies how U.S. states’ COVID-19 policies are associated with adult psychological
health. It uses a new, national survey of U.S. adults aged 18-64 (National Wellbeing Survey) conducted in
Feb/Mar 2021 by PI Monnat. Using its self-reported data on how COVID-19 has affected people’s lives, we will
assess: a) how states’ COVID-19 policies predict individuals’ psychological health approximately one year after
COVID-19 began in the U.S., b) how economic, social, and health care conditions help explain the associations;
and c) how the associations vary by age, sex, race/ethnicity, and education. Aim 2 identifies how U.S. states’
COVID-19 policies affected fatal drug overdose and suicide rates at the county level. Using mortality data from
the National Vital Statistics System, we will assess: a) the immediate and lagged effects of states’ COVID-19
policies on county-level fatal drug overdose and suicide rates among adults aged 18 and older, b) how economic,
social, and health care conditions explain these effects, and c) variation by age, sex, and race/ethnicity. Aim 3
collects four new annual waves of the NWS, in close collaboration with the Consortium, to identify longer-term
consequences of states’ COVID-19 policies and individuals’ adaptations on adult psychological health.
COVID-19 大流行及其可能对全球经济产生深远影响的缓解政策
美国成年人的心理健康状况,包括因药物过量和自杀而死亡的风险。
随着 COVID-19 的传播,美国一些州颁布了居家令和企业关闭等政策。
为了减轻对经济和健康的不利影响,一些州颁布了暂停驱逐和延长驱逐等政策
这些政策可能影响成年人的心理健康和相关死亡率。
通过社会孤立、工作与家庭冲突、人际紧张、经济福祉、就业中断,
该提案的首要目标是严格评估州级 COVID-19 的情况。
缓解政策影响了心理健康以及因吸毒过量和自杀而导致的相关死亡率
该项目意义重大,并将产生持续影响,因为:1)
确定各州的缓解政策如何影响短期和长期的心理健康和死亡率
术语,2) 利用成年人对 COVID-19 和缓解政策如何影响他们的生活的自我报告,
心理健康与药物过量和自杀死亡率的县级行政数据,以及 3)
根据经验制定有意义的国家缓解政策综合措施,以评估其对
该项目的创新之处在于:1)使用并扩展了新颖的调查数据。
来自工作年龄成年人的关于流行病及其缓解政策如何影响他们的生活的信息,2) 最近使用-
开发了分析包含高维和相关数据的大型上下文数据集的方法
3)重点关注政策对心理健康和相关死亡原因的影响,特别是药物-
从短期和长期来看,该项目将通过三个方面实现其目标。
具体目标 1 确定美国各州的 COVID-19 政策与成人心理的关系。
它使用了一项针对 18-64 岁美国成年人的新的全国调查(全国幸福感调查)。
2021 年 2 月/3 月,作者:PI Monnat,我们将利用其关于 COVID-19 如何影响人们生活的自我报告数据。
评估:a) 各州的 COVID-19 政策如何预测大约一年后个人的心理健康状况
COVID-19 始于美国,b) 经济、社会和医疗保健条件如何帮助解释这些关联;
c) 这些关联如何因年龄、性别、种族/族裔和教育程度而变化。目标 2 确定美国各州的情况如何。
根据死亡率数据,COVID-19 政策对县级药物过量和自杀率产生了致命影响。
在国家人口动态统计系统中,我们将评估:a) 各州 COVID-19 的直接影响和滞后影响
关于 18 岁及以上成年人致命药物过量和自杀率的县级政策,b) 经济、
社会和医疗保健条件解释了这些影响,以及 c) 年龄、性别和种族/民族的差异 目标 3。
与联盟密切合作,收集 NWS 的四个新年度浪潮,以确定长期
各州的 COVID-19 政策和个人的适应对成人心理健康的影响。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Political Economy of the COVID-19 Pandemic: How State Policies Shape County-Level Disparities in COVID-19 Deaths.
COVID-19 大流行的政治经济学:州政策如何影响县级 COVID-19 死亡人数差异。
- DOI:
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Sun, Yue;Bisesti, Erin M
- 通讯作者:Bisesti, Erin M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shannon M Monnat其他文献
Shannon M Monnat的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shannon M Monnat', 18)}}的其他基金
Geographic Trends And Disparities In Psychosocial Wellbeing, Health Behaviors, And Mortality In Midlife
社会心理健康、健康行为和中年死亡率的地理趋势和差异
- 批准号:
10712146 - 财政年份:2023
- 资助金额:
$ 41.76万 - 项目类别:
States' COVID-19 Mitigation Policies and Psychological Health, Drug Overdose, and Suicide among U.S. Adults
各州的 COVID-19 缓解政策以及美国成年人的心理健康、药物过量和自杀
- 批准号:
10422534 - 财政年份:2021
- 资助金额:
$ 41.76万 - 项目类别:
States' COVID-19 Mitigation Policies and Psychological Health, Drug Overdose, and Suicide among U.S. Adults
各州的 COVID-19 缓解政策以及美国成年人的心理健康、药物过量和自杀
- 批准号:
10493415 - 财政年份:2021
- 资助金额:
$ 41.76万 - 项目类别:
相似国自然基金
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
D.formicigenerans菌通过调控FoxP3-Treg影响PD-1抑制剂所致免疫相关不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of a phenotypic screening assay for novel compounds that inhibit peripheral pain-sensing neurons
开发抑制外周痛觉神经元的新型化合物的表型筛选试验
- 批准号:
10650640 - 财政年份:2023
- 资助金额:
$ 41.76万 - 项目类别:
Maternal inflammation in relation to offspring epigenetic aging and neurodevelopment
与后代表观遗传衰老和神经发育相关的母体炎症
- 批准号:
10637981 - 财政年份:2023
- 资助金额:
$ 41.76万 - 项目类别:
Growth plate-targeted IGF1 to treat Turner Syndrome
生长板靶向 IGF1 治疗特纳综合征
- 批准号:
10819340 - 财政年份:2023
- 资助金额:
$ 41.76万 - 项目类别:
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM) Research Core & MHD-CE
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686545 - 财政年份:2023
- 资助金额:
$ 41.76万 - 项目类别:
Examining the effects of Global Budget Revenue Program on the Costs and Quality of Care Provided to Cancer Patients Undergoing Chemotherapy
检查全球预算收入计划对接受化疗的癌症患者提供的护理成本和质量的影响
- 批准号:
10734831 - 财政年份:2023
- 资助金额:
$ 41.76万 - 项目类别: